Pharma stocks crater as investors brace for billions in heartburn drug litigation charges
Chemicals/Chemical Products

Pharma stocks crater as investors brace for billions in heartburn drug litigation charges

Shares of GlaxoSmithKline, Sanofi and Haleon all sold off sharply this week, shedding tens of billions in market value, amid investor fear over potential U.S. litigation charges focused on popular heartburn drug Zantac. This has…